| Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis W Zhou, MY Fong, Y Min, G Somlo, L Liu, MR Palomares, Y Yu, A Chow, ... Cancer cell 25 (4), 501-515, 2014 | 1535 | 2014 |
| Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis MY Fong, W Zhou, L Liu, AY Alontaga, M Chandra, J Ashby, A Chow, ... Nature cell biology 17 (2), 183-194, 2015 | 1114 | 2015 |
| Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins M Guix, AC Faber, SE Wang, MG Olivares, Y Song, S Qu, C Rinehart, ... The Journal of clinical investigation 118 (7), 2609-2619, 2008 | 636 | 2008 |
| HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors SE Wang, A Narasanna, M Perez-Torres, B Xiang, FY Wu, S Yang, ... Cancer cell 10 (1), 25-38, 2006 | 587 | 2006 |
| CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells A Tsuyada, A Chow, J Wu, G Somlo, P Chu, S Loera, T Luu, AX Li, X Wu, ... Cancer research 72 (11), 2768-2779, 2012 | 425 | 2012 |
| Cross-kingdom inhibition of breast cancer growth by plant miR159 AR Chin, MY Fong, G Somlo, J Wu, P Swiderski, X Wu, SE Wang Cell research 26 (2), 217-228, 2016 | 390 | 2016 |
| Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells W Yan, X Wu, W Zhou, MY Fong, M Cao, J Liu, X Liu, CH Chen, O Fadare, ... Nature cell biology 20 (5), 597-609, 2018 | 377 | 2018 |
| Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB A Chow, W Zhou, L Liu, MY Fong, J Champer, D Van Haute, AR Chin, ... Scientific reports 4 (1), 5750, 2014 | 354 | 2014 |
| Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM Y Wang, Y Yu, A Tsuyada, X Ren, X Wu, K Stubblefield, EK Rankin-Gee, ... Oncogene 30 (12), 1470-1480, 2011 | 342 | 2011 |
| The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation Y Yu, SE Wang, GS Hayward Immunity 22 (1), 59-70, 2005 | 334 | 2005 |
| Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers R Ghosh, A Narasanna, SE Wang, S Liu, A Chakrabarty, JM Balko, ... Cancer research 71 (5), 1871-1882, 2011 | 302 | 2011 |
| De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer X Wu, G Somlo, Y Yu, MR Palomares, AX Li, W Zhou, A Chow, Y Yen, ... Journal of translational medicine 10, 1-10, 2012 | 275 | 2012 |
| Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor β-induced cell motility Y Ueda, S Wang, N Dumont, JY Yi, Y Koh, CL Arteaga Journal of Biological Chemistry 279 (23), 24505-24513, 2004 | 210 | 2004 |
| Transforming growth factor β engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab SE Wang, B Xiang, M Guix, MG Olivares, J Parker, CH Chung, ... Molecular and cellular biology, 2008 | 204 | 2008 |
| Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2 M Shen, C Dong, X Ruan, W Yan, M Cao, D Pizzo, X Wu, L Yang, L Liu, ... Cancer research 79 (14), 3608-3621, 2019 | 167 | 2019 |
| Transforming growth factor β induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton SE Wang, B Xiang, R Zent, V Quaranta, A Pozzi, CL Arteaga Cancer research 69 (2), 475-482, 2009 | 167 | 2009 |
| Reduction of cytosolic p27Kip1 inhibits cancer cell motility, survival, and tumorigenicity FY Wu, SE Wang, ME Sanders, I Shin, F Rojo, J Baselga, CL Arteaga Cancer research 66 (4), 2162-2172, 2006 | 165 | 2006 |
| MiR-205 in cancer: an angel or a devil? AY Qin, XW Zhang, L Liu, JP Yu, H Li, SZE Wang, XB Ren, S Cao European journal of cell biology 92 (2), 54-60, 2013 | 154 | 2013 |
| CCAAT/enhancer-binding protein-α is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV … SE Wang, FY Wu, Y Yu, GS Hayward Journal of virology 77 (17), 9590-9612, 2003 | 147 | 2003 |
| Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study R Li, C Wang, L Liu, C Du, S Cao, J Yu, SE Wang, X Hao, X Ren, H Li Cancer immunology, immunotherapy 61, 2125-2133, 2012 | 144 | 2012 |
